Approval · Notice of Compliance 12629 · 2011
RAN-FINASTERIDE: Notice of Compliance 12629
Issued September 13, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12629
- Date
- September 13, 2011
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New Manufacturer and Prouct Name
- Therapeutic class
- Type II 5 Alpha-reductase Inhibitor
- Canadian reference product
- PROSCAR (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-FINASTERIDE | 02371820 | Cancelled Post Market |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB